Dr Reddy S Laboratories Limited
Sensex up 248 pts at 49,517; Nifty at 14,563; SBI, Airtel soar 4%, RIL 3%
PM holds virtual meet with teams developing, manufacturing Covid-19 vaccine
Dr Reddy's gets nod for 2/3 vaccine trial; Key updates about the virus
Strong support exists for Nifty at 10,900: CapitalVia Global Research
Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks

Dr Reddy's Labs gains for second straight day on Covid vaccine deal
New launches, patents: Multiple catalysts for Dr Reddy's US business
Dr Reddy's launches cancer drug Abiraterone Acetate in US market
Dr Reddy's closes Wockhardt branded generics deal on modified terms
Centre keen on testing Gilead's remdesivir to combat coronavirus

Dr Reddy's hits 52-week high after USFDA issues EIR for Srikakulam facility
India gears up for patient trials on 20 different drugs for Covid-19
Dr Reddy's denies reports it is in talks with Gilead for Covid-19 antiviral
Dr Reddy's launches generic Ziprasidone Mesylate for injection in US
Dr Reddy's gets 1 observation from USFDA after inspecting Hyderabad plant
Dr Reddy's gets nod for amalgamation of Dr Reddy's Holdings into company
China opens public hospitals for Dr Reddy's Laboratories generic drugs
PSAI segment decline pulls down Dr Reddy's Q1 show
Dr Reddy's recalls cholesterol lowering Atorvastatin tablets in the US